by The China scar treatment market provides solutions to remove scars from accidents, surgeries or acne. Scar treatment products include topical scar creams, gels, silicone sheets, laser treatment and surgery. These products help in scar lightening and remodeling by increasing collagen production. The need for scar treatment is growing due to rising road accidents, increase in cosmetic procedures and prevalence of acne in China.
The Global China Scar Treatment Market Demand is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the China Scar Treatment are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. The key players are focusing on new product launches and expansion strategies to gain higher market share.
Growing incidences of road accidents, sports injuries and surgery related scars are fueling the demand for scar treatment in China. Rising awareness about scar removal treatments and increasing medical tourism are also propelling the market growth.
The scar treatment market in China is witnessing significant growth owing to increasing availability of advanced scar treatments and expansion of key players in different cities and provinces of China. Players are establishing manufacturing plants and distribution networks to cater to the growing scar treatment demand.
Market key trends
One of the key trends in the China scar treatment market is increasing adoption of laser treatment. Laser therapy is gaining popularity for scar removal due to its non-invasiveness and faster healing time. Advances in laser technology like fractional CO2 and pulsed dye laser (PDL) allow effective treatment of scars with minimal side effects. Growing availability of advanced laser devices at affordable costs will further drive their adoption in China over the forecast period.
Porter’s Analysis
Threat of new entrants: Scar treatment procedures require expensive investment in R&D and regulatory approvals posing high entry barriers.
Bargaining power of buyers: Large number of established players gives buyers alternate treatment options to choose from increasing their bargaining power.
Bargaining power of suppliers: Requirement of specialized raw materials and components from few suppliers increases their bargaining power.
Threat of new substitutes: Advancement in medical technologies may lead to development of new substitute scar treatment methods posing threat.
Competitive rivalry: Intense competition among established players to gain market share through differentiated offerings and innovations.
China accounts for over 45% of the market value in the Asia Pacific region due to high scar incidences, increasing medical tourism, and rapidly growing healthcare infrastructure. The scar treatment market in Latin America, especially Brazil and Mexico, is expected to grow at the fastest pace during the forecast period supported by growing healthcare penetration and expenditure, and increasing number of cosmetic and burn procedures.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
